Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) Indication "SAFARI"

Completed

Phase N/A Results N/A

Main Contacts

Name Phone E-mail
Bayer Study Director Study Director
Bayer Clinical Trials Contact Contact clinical-trials-contact@bayerhealthcare.com

Other Locations

Name City State Country Status
Name Unavailable Many Locations France Unknown_status_icon